| Ayad Said Makar, MD | |
|
8110 Mango Ave, Fontana, CA 92335-3603 | |
| (909) 357-1595 | |
| (909) 357-1203 |
| Full Name | Ayad Said Makar |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 62 Years |
| Location | 8110 Mango Ave, Fontana, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265491765 | NPI | - | NPPES |
| 00A454470 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G80706 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Medical Group, Inc. | 4880667609 | 18 |
News Archive
When Shakespeare called sleep "nature's soft nurse," he was definitely onto something. Centuries later researchers have found that inadequate sleep in children affects their emotional functioning in ways that may predict longer-term social problems. A new study, published in Affective Science by University of Houston professor of psychology Candice Alfano, examined whether changes in children's facial expressions of emotion after sleep restriction predict social problems concurrently and/or over time.
Stanley, Inc., a leading provider of systems integration and professional services to the U.S. federal government, today announced that it was awarded two time-and-materials contracts valued at $15 million, with exercise of options, by the U.S. Department of Health and Human Services (DHHS), Office of the National Coordinator (ONC). These two awards follow an award from DHHS that the company announced on August 2, 2010, to provide operation and infrastructure support for the Nationwide Health Information Network. All three awards fall under the company's Chief Information Officer – Solutions and Partners 2 Innovations contract with the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC).
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) today commented on new diagnostic criteria and guidelines for Alzheimer's disease published recently by the National Institute on Aging (NIA) and the Alzheimer's Association, which have been updated for the first time in more than 25 years. The new guidelines discuss the importance of new technologies, including brain imaging and biomarker analysis, in research and clinical diagnosis. They describe Alzheimer's disease at a preclinical stage, Mild Cognitive Impairment (MCI) due to Alzheimer's disease, and dementia due to Alzheimer's pathology.
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
Alexion Pharmaceuticals, Inc. today announced that the European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that the therapeutic indication for Soliris® (eculizumab) be extended to include the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS) in Europe.
› Verified 3 days ago
| Entity Name | Pinnacle Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376876912 PECOS PAC ID: 4880667609 Enrollment ID: O20040818001020 |
News Archive
When Shakespeare called sleep "nature's soft nurse," he was definitely onto something. Centuries later researchers have found that inadequate sleep in children affects their emotional functioning in ways that may predict longer-term social problems. A new study, published in Affective Science by University of Houston professor of psychology Candice Alfano, examined whether changes in children's facial expressions of emotion after sleep restriction predict social problems concurrently and/or over time.
Stanley, Inc., a leading provider of systems integration and professional services to the U.S. federal government, today announced that it was awarded two time-and-materials contracts valued at $15 million, with exercise of options, by the U.S. Department of Health and Human Services (DHHS), Office of the National Coordinator (ONC). These two awards follow an award from DHHS that the company announced on August 2, 2010, to provide operation and infrastructure support for the Nationwide Health Information Network. All three awards fall under the company's Chief Information Officer – Solutions and Partners 2 Innovations contract with the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC).
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) today commented on new diagnostic criteria and guidelines for Alzheimer's disease published recently by the National Institute on Aging (NIA) and the Alzheimer's Association, which have been updated for the first time in more than 25 years. The new guidelines discuss the importance of new technologies, including brain imaging and biomarker analysis, in research and clinical diagnosis. They describe Alzheimer's disease at a preclinical stage, Mild Cognitive Impairment (MCI) due to Alzheimer's disease, and dementia due to Alzheimer's pathology.
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
Alexion Pharmaceuticals, Inc. today announced that the European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that the therapeutic indication for Soliris® (eculizumab) be extended to include the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS) in Europe.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ayad Said Makar, MD Po Box 12209, San Bernardino, CA 92423-2209 Ph: (909) 357-1595 | Ayad Said Makar, MD 8110 Mango Ave, Fontana, CA 92335-3603 Ph: (909) 357-1595 |
News Archive
When Shakespeare called sleep "nature's soft nurse," he was definitely onto something. Centuries later researchers have found that inadequate sleep in children affects their emotional functioning in ways that may predict longer-term social problems. A new study, published in Affective Science by University of Houston professor of psychology Candice Alfano, examined whether changes in children's facial expressions of emotion after sleep restriction predict social problems concurrently and/or over time.
Stanley, Inc., a leading provider of systems integration and professional services to the U.S. federal government, today announced that it was awarded two time-and-materials contracts valued at $15 million, with exercise of options, by the U.S. Department of Health and Human Services (DHHS), Office of the National Coordinator (ONC). These two awards follow an award from DHHS that the company announced on August 2, 2010, to provide operation and infrastructure support for the Nationwide Health Information Network. All three awards fall under the company's Chief Information Officer – Solutions and Partners 2 Innovations contract with the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC).
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) today commented on new diagnostic criteria and guidelines for Alzheimer's disease published recently by the National Institute on Aging (NIA) and the Alzheimer's Association, which have been updated for the first time in more than 25 years. The new guidelines discuss the importance of new technologies, including brain imaging and biomarker analysis, in research and clinical diagnosis. They describe Alzheimer's disease at a preclinical stage, Mild Cognitive Impairment (MCI) due to Alzheimer's disease, and dementia due to Alzheimer's pathology.
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
Alexion Pharmaceuticals, Inc. today announced that the European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that the therapeutic indication for Soliris® (eculizumab) be extended to include the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS) in Europe.
› Verified 3 days ago
Dr. Silas Chun-wing Chiu, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-5000 Fax: 310-782-1763 | |
Kim Trinh, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 951-333-1581 | |
Scott Alan Walker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910 | |
Mr. Santiago Lopez Jr., Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 833-574-2273 Fax: 833-574-2273 | |
Greg A. Capestany, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910 | |
David G. Reiley, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910 | |
Dr. Tina Ann Nguyen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 800-464-4000 |